12 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer and chief scientific officer
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
decades of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive … of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
of experience in cancer immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer … immunotherapy, cell and gene therapy and regenerative medicine. Dr. Finer previously served as our chief executive officer and chief scientific
424B4
e7nst
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
xnx236ph
11 Sep 20
IPO registration
4:49pm
DRS/A
ymcywgtsyu42 mdr
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
x28mgaeg il6emjl
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
tmur8mkjsq w86q
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
ck6ht bgp5quq4m
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next